3-Chloro-4-methoxy-5-nitrobenzoic acid, 95%, 1g

Ethyl 2-(trifluoromethylsulfonyloxy)benzoate, 96.0%, 5g

1-ethyl-N-[2-(2-pyridinyl)ethyl]-4-piperidinamine tri[(2Z)-2-butenedioate], 95.0%, 1g

Polvere di bismuto, min 99,5%, maglia circa, 100 g, confezione in vetro

1-(Azetidin-3-yl)piperidin-2-one hydrochloride, 98%, 5g

4-Chloro-2-methoxybenzoic acid, 95.0%, 100g

4-Propylphenol, 97.0%, 100g

2-cloroanilina, >=98%, per sintesi, 1 L, confezione in vetro

Ethyl 4-methylenecyclohexanecarboxylate, 95.0%, 250mg

(R)-2-Amino-6-((tert-butoxycarbonyl)amino)hexanoic acid, 95.0%, 1g

(2-Hydroxy-4-methylphenyl)boronic acid, 95.0%, 250mg

2,3-Dihydroxy-quinoxaline-6-carboxylic acid methyl ester, 95.0%, 100mg

1,2-DIFLUOROCYCLOHEX-2-ENECARBOXYLIC ACID, 95.0%, 250mg